Provider groups, especially community oncologists, are worried that drug prices negotiated under the IRA will drastically ...

The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...

ADVI Health’s Lindsay Greenleaf discusses how most-favored-nation drug pricing is playing out among specialty drugs. Drug ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

Coramitug is designed to clear toxic protein deposits from the heart, offering a new approach to treating ATTR cardiomyopathy ...

The FDA has accepted a new drug application (NDA) for zipalertinib for the treatment of patients with locally advanced or ...

Cell and gene therapies are currently niche products, even within specialty pharmacy, drugs that, by most definitions, are ...

Health system specialty pharmacy programs are expanding beyond traditional roles to support value-based care, according to a ...

Allo and Ciaramatero presented today at Asembia’s 2026 Specialty Pharmacy Summit, being held in Las Vegas from April 26 to April 30. They spoke during a session called, ‘Healthcare and Drug Pricing at ...

A pharmacist-led specialty pharmacy care model presented at AXS26 shows improved A1C control, fewer hospital visits and lower ...

In this clip, Mike Ciarametaro, managing director of policy at Avalere Health, explains all the “moving pieces” that could ...

Attendance approaches 10,000 with extensive corporate representation, underscoring Asembia’s role as a central convening ...